The EPS projection of Procter & Gamble Co (NYSE:PG) for quarter ended 2016-09-30 is $1. Last week, the EPS forecast was $1 against target of $1, a month earlier. Two months ago, this estimate was $1 versus forecast of $1 three months earlier, implying a deviation of 0%.
Procter & Gamble Co (NYSE:PG) stated that 18 days ago, its stock price was positively revised 0 times while negative revisions were 3.
In last week, the experts lowered EPS 0 times and increased EPS 0 times. In last 30, 120, 60 and 90 days, the experts upped revisions 0 , 0, 0, and 0, correspondingly.
EPS estimate downgrade for Procter & Gamble Co (NYSE:PG) in the preceding 30, 120, 60 and 90 days were 0, 4, 0, and 4, correspondingly.
Procter & Gamble Co (NYSE:PG) EPS target for the quarter closed 3 was $1, based on 10 recommendations. As reported on 2016-04-26 the EPS was $0.86. The change was $0.05, implying a percentage deviation of 6.17%. The projections showed a standard deviation of 0.02.
Quarterly Sales Estimates
Procter & Gamble Co (NYSE:PG) yearly sales prediction for the fiscal 2017 stands at $16241.525 and the median estimate is at $16245.05. Almost 4 analysts issued sales target.
Highest sales target is $16381 while the lowest target is $16095 showing standard deviation of 153.029%.
As many as 4 analysts have sales targets revised upside while 4 reduced sales estimates, implying a deviation of 0%.
Last month, 4 revised sales number projection on upside while 4 lowered the sales projections, implying a deviation of 0%.
A quarter ago, 4 hiked sales target and 4 reduced sales forecast. Procter & Gamble Co (NYSE:PG) announced that the deviation in forecast was 0.619%.
1 Chart Pattern Every Investor Should Know
This little-known pattern preceded moves of 578% in ARWR, 562% in LCI, 513% in ICPT, 439% in EGRX, 408% in ADDUS and more...